PD-1的翻译后修改:癌症免疫治疗的潜在目标
Te-An Lee1,2, En-Yun Tsai1,3, Shou-Hou Liu1
1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Cancer research
|January 17, 2024
概括
针对T细胞中编程死亡-1 (PD-1) 的翻译后修改 (PTM) 可以克服癌症中的免疫抑制. 这种方法增强了抗瘤免疫力,并改善了对抗PD-1疗法的反应.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 效应因子T细胞激活升级调节编程死亡-1 (PD-1),通过其联体PD-L1.1抑制T细胞活性.
- 翻译后的修饰 (PTMs),如糖化,化,无化和棕化,对PD-1蛋白的稳定性,局部化和相互作用进行了关键调节.
研究的目的:
- 探索针对PD-1 PTMs作为增强抗瘤免疫力的治疗策略.
- 研究调节PD-1 PTM的方法,以克服PD-1介导的癌症免疫抑制.
主要方法:
- 研究小分子抑制剂以抑制诱导PD-1 PTM的信号通路.
- 使用单克隆抗体 (mAbs) 直接向T细胞上的PD-1 PTM.
主要成果:
- 初步研究表明,针对PD-1 PTM是一种有前途的治疗策略.
- 调节PD-1 PTM显示有潜力提高抗PD-1疗法的疗效.
结论:
- 准PD-1 PTM是一种新的方法,可以增强抗PD-1 癌症免疫疗法.
- 对PD-1 PTM的进一步研究可能会导致改善治疗方法,以增强抗瘤反应.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


